GlassScriptPhysician profile
Izumi Cabrera
NPI 1346430584
$2,501.87
in general payments reported to CMS, 2019-2025
15 companies · $539 in 2025
The $539 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2021: $24.06 · 2022: $432 · 2023: $668 · 2024: $635 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,842.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $1,355.04 | 2022-2025 | Myosure Tissue Removal Device, Acessa Provu System, Fluent Fluid Management System |
| Abbvie INC. | $278.22 | 2019-2024 | |
| Ethicon US, LLC | $218.40 | 2019-2023 | Dermabond, Stratafix, Harmonic |
| Astellas Pharma US INC | $124.20 | 2023-2025 | Veozah |
| Biogen, INC. | $108.44 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $107.13 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Evofem Biosciences, INC. | $58.79 | 2021-2023 | Phexxi |
| Medtronic, INC. | $43.43 | 2024 | Truclear |
| Myriad Genetic Laboratories, INC. | $42.75 | 2023 | Precisetumor |
| Exact Sciences Corporation | $40.90 | 2023-2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $34.64 | 2023-2024 | Myfembree |
| Shield Therapeutics INC | $27.64 | 2023 | Accrufer |
| Myovant Sciences INC. | $21.68 | 2022 | |
| Meditrina | $20.52 | 2024 | |
| Pfizer INC. | $20.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Izumi Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.